Gilad Kunis
Impact in
- Neurology top 0.5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Amyotrophic Lateral Sclerosis Research
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
Papers in
- Neurology 11
- Neuroinflammation and Neurodegeneration Mechanisms 11
- Amyotrophic Lateral Sclerosis Research 2
-
- Alzheimer's disease research and treatments 4
- Co-authors
- Michal Schwartz (11 shared papers)Oleg Butovsky (5 shared papers)Maya Koronyo‐Hamaoui (7 shared papers)Hagit Cohen (2 shared papers)Eran Ophir (2 shared papers)Gennady Landa (2 shared papers)Omer Miller (3 shared papers)Kuti Baruch (2 shared papers)
- Journals
- PLoS ONE (2 papers)Journal of Neurochemistry (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)BioDrugs (1 paper)Brain (1 paper)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Gilad Kunis
15 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Neurology 795
- Biological Psychiatry 220
- Developmental Neuroscience 143
- Physiology 414
- Immunology 310
Countries citing papers authored by Gilad Kunis
This map shows the geographic impact of Gilad Kunis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilad Kunis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilad Kunis more than expected).
Fields of papers citing papers by Gilad Kunis
This network shows the impact of papers produced by Gilad Kunis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilad Kunis. The network helps show where Gilad Kunis may publish in the future.
Co-authors
The 25 scholars most cited alongside Gilad Kunis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 315 | |
| 2 | 2013 | 248 | |
| 3 | 2007 | 137 | |
| 4 | Butovsky, O. et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl Acad. Sci. USA 103, 11784-11789 | 2006 | 129 |
| 5 | 2009 | 93 | |
| 6 | 2015 | 81 | |
| 7 | 2007 | 66 | |
| 8 | 2011 | 66 | |
| 9 | 2011 | 53 | |
| 10 | 2008 | 12 | |
| 11 | 2011 | 10 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 5 | |
| 14 | 2009 | 5 | |
| 15 | Koronyo-Hamaoui, M. et al. Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. J. Neurochem. 111, 1409-1424 | 2009 | 5 |
About Gilad Kunis
Gilad Kunis is a scholar working on Neurology, Physiology, Neurology, Immunology and Genetics, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (11 papers), Alzheimer's disease research and treatments (4 papers), Neurogenesis and neuroplasticity mechanisms (2 papers), Amyotrophic Lateral Sclerosis Research (2 papers), Tryptophan and brain disorders (2 papers), Immune cells in cancer (2 papers), Hydrogen's biological and therapeutic effects (1 paper) and S100 Proteins and Annexins (1 paper). The work is most often cited by research in Neurology (795 citations), Biological Psychiatry (220 citations), Developmental Neuroscience (143 citations), Physiology (414 citations) and Immunology (310 citations). Gilad Kunis has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Michal Schwartz, Oleg Butovsky, Maya Koronyo‐Hamaoui, Hagit Cohen, Eran Ophir, Gennady Landa, Omer Miller, Kuti Baruch, Tamara Berkutzki and Neta Rosenzweig. Their work appears in journals such as PLoS ONE, Journal of Neurochemistry, Frontiers in Bioengineering and Biotechnology, BioDrugs and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.